MiRNA-548ah, a potential molecule associated with transition from immune tolerance to immune activation of chronic hepatitis B

International Journal of Molecular Sciences

Volumn 15, Issue 8, 2014, Pages 14411-14426

  Xing, Tong Jing ^a   Xu, Hong Tao ^a   Yu, Wen Qing ^a   Wang, Bian ^a   Zhang, Jing ^a  

^a Department of Infectious Diseases Taizhou People's Hospital ^*  (China)

Author keywords

Chronic hepatitis B; Immune activation; Immune tolerance; MicroRNA

Indexed keywords

COMPLEMENTARY DNA; FIREFLY LUCIFERASE; GAMMA INTERFERON RECEPTOR 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MICRORNA; MICRORNA 548AH; MITOGEN ACTIVATED PROTEIN KINASE; PLASMID DNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; GAMMA INTERFERON RECEPTOR; INTERFERON RECEPTOR;

ADULT; ARTICLE; BOOK; CHROMOSOME 5; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL ELECTROPHORESIS; GENE ONTOLOGY; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HYBRIDIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; KYOTO ENCYCLOPEDIA OF GENES AND GENOMES; LUCIFERASE ASSAY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE TRANSITION; PLASMID; PROTEIN RNA BINDING; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY; WESTERN BLOTTING; 3' UNTRANSLATED REGION; CELL LINE; GENETICS; IMMUNOLOGY; PHYSIOLOGY;

3' UNTRANSLATED REGIONS; CELL LINE; HEPATITIS B, CHRONIC; HUMANS; IMMUNE TOLERANCE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERFERON;

EID: 84926467704     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150814411     Document Type: Article

References (33)

1. Lee, W.M.; Hepatitis, B. Virus infection. N. Engl. J. Med. 1997, 337, 1733-1745.
2. Chisari, F.V. Viruses, Immunity and Cancer: Lessons from hepatitis B. Am. J. Pathol. 2000, 156, 1117-1132.
3. Das, A.; Maini, M.K. Innate and adaptive immune responses in hepatitis B virus infection. Dig. Dis. 2010, 28, 126-132.
4. Tsai, H.T.; Tsai, T.H.; Lu, T.M.; Yang, C.C. Immunopathology of hepatitis B virus infection. Int. Rev. Immunol. 2008, 27, 427-446.
5. Maini, M.K.; Schurich, A. The molecular basis of the failed immune response in chronic HBV: Therapeutic implications. J. Hepatol. 2010, 52, 616-619.
6. Revill, P.; Yuan, Z. New insights into how HBV manipulates the innate immune response to establish acute and persistent infection. Antivir. Ther. 2013, 18, 1-15.
7. Ait-Goughoulte, M.L.; Lucifora, J.; Zoulim, F.; Durantel, D. Innate antiviral immune responses to hepatitis B virus. Viruses 2010, 2, 1394-1410.
8. Dykxhoorn, D.M.; Lieberman, J. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu. Rev. Med. 2005, 56, 401-423.
9. Esau, C.C.; Moniu, B.P. Theraeutic potential for micro-RNAs. Adv. Drug Deliv. Rev. 2007, 59, 101-114.
10. Li, Q.J.; Chau, J.; Ebert, P.J.; Sylvester, G.; Min, H.; Liu, G.; Braich, R.; Manoharan, M.; Soutschek, J.; Skare, P. et al. MIR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007, 129, 147-161.
11. Lu, L.F.; Boldin, M.P.; Chaudhry, A.; Lin, L.L.; Taganov, K.D.; Hanada, T.; Yoshimura, A.; Baltimore, D.; Rudensky, A.Y. Function of miR-146a in controlling Treg cell- mediated regulation of Th1 responses. Cell 2010, 142, 914-929.
12. Contreras, J.; Rao, D.S. MicroRNAs in inflammation and immune response. Leukemia 2012, 26, 404-413.
13. Dai, R.; Ahmed, S.A. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl. Res. 2011, 157, 163-179.
14. Lok, A.S.; McMahon, B.J. Chronic hepatitis B. Hepatology 2007, 45, 507-539.
15. Feng, I.-C.; Koay, L.-B.; Sheu, M.-J.; Kuo, H.-T.; Sun, C.-S.; Lee, C.; Chuang, W.-L.; Liao, S.-K.; Wang, S.-L.; Tang, L.-Y. et al. HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection. J. Biomed. Sci. 2007, 14, 43-57.
16. Wang, L.; Xie, Q.; Gong, B.D.; An, B.Y.; Xu, Y.M.; Cai, W.; Wang, H.; Zhou, H.; Guo, S.; Yu, H. et al. The expression of microRNAs in the peripheral blood mononuclear cells of the patients with hepatitis B virus infection. Chin. J. Infect. Dis. 2010, 28, 473-479.
17. Zhang, J.; Shi, J.F.; Gao, C.; Jiang, M.; Wang, Y.L.; Gan, J.H.; Jiang, M.H.; Gu, G.H. The significance and the change of miRNAs expression profile of peripheral blood mononuclear cell in different period of HBV infection. Chin. J. Lab. Med. 2012, 35, 544-549.
18. Wang, S.; Qiu, L.; Yan, X.; Jin, W.; Wang, Y.; Chen, L.; Wu, E.; Ye, X.; Gao, G.F.; Wang, F. et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity. Hepatology 2012, 55, 730-741.
19. Jiang, X.; Kanda, T.; Wu, S.; Nakamura, M.; Miyamura, T.; Nakamoto, S.; Banerjee, A.; Yokosuka, O. Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity. World J. Gastroenterol. 2014, 20, 7197-7206.
20. Chen, L.; Li, C.Z.; Peng, Z.Q.; Zhao, J.X.; Gong, G.Z.; Tan, D.M. MiR-197 expression in peripheral blood mononuclear cells from hepatitis B virus-infected patients. Gut Liver 2013, 7, 335-342.
21. Pan, X.B.; Ma, H.; Jin, Q.; Wei, L. Characterization of microRNA expression profiles associated with hepatitis B virus replication and clearance in vivo and in vitro. J. Gastroenterol. Hepatol. 2012, 27, 805-812.
22. Winther, T.N.; Bang-Berthelsen, C.H.; Heiberg, I.L.; Pociot, F.; Hoqh, B. Differential plasma microRNA profiles in HbeAg positive and HBeAg negative children with chronic hepatitis B. PLoS One 2013, 8, e58236.
23. Liang, T.; Guo, L.; Liu, C. Genome-wide analysis of mir-548 gene family reveals evolutionary and functional implications. J. Biomed. Biotechnol. 2012, 2012, 679563.
24. Li, N.; Chen, M.Q.; Cheng, Q.; Zhu, M.Q.; Shi, G.F. Identification of microRNA mediating type I interferon pathway in chronic hepatitis B patients. Chin. J. Viral Dis. 2012, 2, 107-112.
25. Li, Y.; Xie, J.; Xu, X.; Wang, J.; Ao, F.; Wan, Y.; Zhu, Y. MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1. Protein Cell 2013, 4, 130-141.
26. Tsai, S.L.; Sheen, I.S.; Chien, R.N.; Chu, C.M.; Huang, H.C.; Chuang, Y.L.; Lee, T.H.; Liao, S.K.; Lin, C.L.; Kuo, G.C. et al. Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: Tetramer assay and therapeutic implications. J. Biomed. Sci. 2003, 10, 120-135.
27. Hao, J.; Jin, W.; Li, X.; Wang, S.; Zhang, X.; Fan, H.; Li, C.; Chen, L.; Gao, B.; Liu, G. et al. Inhibition of alpha interferon (IFN-α)-induced microRNA-122 negatively affects the anti-hepatitis B virus efficiency of IFN-α. J. Virol. 2013, 87, 137-147.
28. Chinese Liver Disease Association and Chinese Medical Association Infectious Disease Branch. Chronic hepatitis B Prevention Guide (2010 Edition). Chin. J. Hepatol. 2011, 19, 13-24.
29. Target Scan Homepage. Available online: http://www.targetscan.org (accessed on 16 January, 2014).
30. miRDB Homepage. Available online: http://www.mirdb.org/ (accessed on 16 January 2014).
31. microRNA Homepage. Available online: http://www.microrna.org/microrna/home.do (accessed on 16 January 2014).
32. Gene Ontology Homepage (GO). Available online: http://www.geneontology.org (accessed on 20 January 2014).
33. Kyoto Encyclopedia of Genes and Genomes (KEGG) Homepage. Available online: http://www.genome.jp (accessed on 20 January 2014).